Evidence map›Paper›PMID 38586155›Full record

ArticleFrontiers in pediatrics2024

Case Report: Kawasaki disease associated with acute generalized exanthematous pustulosis secondary to carbocysteine.

Takashi Furuta, Hiroyuki Fukumoto, Mayu Fujiwara, Shinnosuke Fukunaga, Yuichi Ishikawa, Reiji Hirano

Abstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Takashi FurutaDepartment of Pediatrics, Yamaguchi-ken Shimonseki Saiseikai General Hospital, Yamaguchi, Japan.
Hiroyuki FukumotoDepartment of Pediatrics, Yamaguchi-ken Shimonseki Saiseikai General Hospital, Yamaguchi, Japan.
Mayu FujiwaraDepartment of Pediatrics, Yamaguchi-ken Shimonseki Saiseikai General Hospital, Yamaguchi, Japan.
Shinnosuke FukunagaDepartment of Pediatrics, Yamaguchi-ken Shimonseki Saiseikai General Hospital, Yamaguchi, Japan.
Yuichi IshikawaDepartment of Pediatrics, Yamaguchi-ken Shimonseki Saiseikai General Hospital, Yamaguchi, Japan.
Reiji HiranoDepartment of Pediatrics, Yamaguchi-ken Shimonseki Saiseikai General Hospital, Yamaguchi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute generalized exanthematous pustulosis (AGEP) is an uncommon eruption characterized by sterile pustules on an erythematous background, which is usually associated with drugs. AGEP is described as a self-limiting disease with favorable prognosis. We reported a case of Kawasaki Disease (KD) following AGEP. A 3-year-old male, who was admitted with pustules and five days of fever at our hospital, was diagnosed with AGEP. Despite the skin lesions and fever improving drastically after prednisolone therapy, the fever recurred on hospitalization day 5. The following symptoms suggestive of KD also appeared: bulbar conjunctival hyperemia, cervical lymphadenopathy, erythema of the lips, eruption on his trunk, and erythema and edema of the hands and feet. He was diagnosed with KD and treated with intravenous immunoglobulin. He was discharged on the thirteenth day of hospitalization without cardiac complications. Drug-induced lymphocyte stimulation test revealed carbocysteine as the suspected cause of AGEP, which consequently triggered KD. Because a mucosal lesion is uncommon in AGEP, bulbar conjunctival hyperemia suggested that KD sequentially occurred after AGEP. Since AGEP is benign and self-limited in most cases, it is necessary to differentiate other diseases, including KD, when recurrent fever or rash occurs in the course of AGEP.

Indexed as

acute generalized exanthematous pustulosisdamage-associated molecular patternsKawasaki diseasemicrobe-associated molecular patternspathogen-associated molecular patterns

Identifiers

PMID38586155
PMCPMC10995226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.